
Friday, July 27, 2007 12:12:03 AM
26-Jul-2007
Results of Operations and Financial Condition, Other Events, Financial
Item 2.02. Results of Operations and Financial Condition.
On July 26, 2007, Monogram Biosciences, Inc., or Monogram, issued a press release announcing its unaudited financial results for the quarter ended June 30, 2007. A copy of this press release is included herewith as Exhibit 99.1.
Item 8.01. Other Events.
On July 26, 2007, Monogram announced that it will file with the Securities and Exchange Commission a preliminary proxy statement regarding its annual meeting of stockholders, to be held on September 19, 2007. Included in the matters to be voted on is the approval of a series of alternative amendments to Monogram's Amended and Restated Certificate of Incorporation, as amended, to effect, at the discretion of the Board of Directors, (i) a reverse stock split of the Common Stock whereby each outstanding 4, 5, or 6 shares would be combined, converted and changed into one share of Common Stock, and (ii) related reductions in the authorized number of shares of Monogram's Common Stock.
The effectiveness of one of such amendments and the abandonment of the other amendments, or the abandonment of all amendments as permitted under
Section 242(c) of the Delaware General Corporation Law, would be determined by the Board of Directors prior to Monogram's 2008 Annual Meeting of Stockholders.
Recent MGRM News
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2024 09:00:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2024 01:35:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/02/2024 09:13:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2024 01:52:37 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 09:33:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 09:07:08 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/08/2024 03:00:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/30/2024 07:18:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2024 09:05:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2024 01:28:37 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/02/2024 09:23:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2024 09:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 01:35:28 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/11/2024 09:26:27 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/17/2024 08:51:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 10:30:23 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 01:20:40 PM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 05/08/2024 08:55:25 PM
UAV Corp. Expanding in the Global UAV Market, Projected to Exceed $58 Billion by 2027, with Increasing Government and Commercial Sector Adoption • UMAV • Feb 6, 2025 8:30 AM
VAYK Project $700K 2024 Revenue with $150K Net Profit • VAYK • Feb 5, 2025 12:43 PM
UAV Corp (UMAV) Kicks Off Landmark "SKY" Hangar Project with Land Clearing at Costin Airport Setting Stage for Q1 2025 Groundbreaking • UMAV • Feb 5, 2025 8:30 AM
HealthLynked Corp. Releases Annual Shareholder Letter Highlighting Recent Product Development and Strategic Vision for the Future • HLYK • Feb 4, 2025 8:00 AM
Wytec Wins Multi-State Government Contract for AI Gunshot Detection • WYTC • Feb 3, 2025 7:16 AM
UAV Corp. Retains Legal Counsel to Address Legacy Debt from HTTI Era; 500 Million Authorized Shares Confirmed - UAV Corp. Delivers on Strategic Commitments • UMAV • Jan 31, 2025 1:30 PM